* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Provisional agenda
Vaccination policy wikipedia , lookup
Kawasaki disease wikipedia , lookup
Infection control wikipedia , lookup
Behçet's disease wikipedia , lookup
Herd immunity wikipedia , lookup
Marburg virus disease wikipedia , lookup
Henipavirus wikipedia , lookup
Hepatitis B wikipedia , lookup
Immunocontraception wikipedia , lookup
Multiple sclerosis research wikipedia , lookup
Germ theory of disease wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Childhood immunizations in the United States wikipedia , lookup
Food and Agriculture Organization of the United Nations The Global Control of FMD Tools, Ideas and Ideals Erice, Sicily 14-17 October 2008 Monday 13 October 13:00 Registration opens – Palazzo Sales 17:00 First view of posters – Palazzo Sales 19:00-21:00 Tuesday 14 Welcome reception – San Giovanni October 09:00-09:30 Opening 09:30-10:00 Keynote FAO/OIE representative: Global FMD control: opportunities and constraints 10:00-10:15 Global FMDV distribution and regional virus reservoirs: an opportunity to divide and control? J. Hammond 10:15-10:30 Hemispheric Program for the Eradication of FMD (PHEFA) Successes and Challenges V. Saraiva 10:30-10:45 FMD Type C situation – The first target for eradication P. Roeder 10:45-11:15 11:15-11:30 11:30-11:45 Coffee break (Posters and YouTube viewing) 11:45-12:00 Constraints and opportunities for the control of foot-and-mouth disease in India D. Hemadri Session 1 Global FMD control through regional co-ordinated actions: opportunities and constraints Progress in FMD control in Iran: and perspective on longer term control in the region V. Otarod Virus diversity and vaccine selection: Russia, CIS-countries and Mongolia 2000–2007 A. Scherbakov 12:00-12:15 The global FMD research alliance (GFRA) - an R&D response to the major constraints to global FMD control C. G. Gay 12:15-13:00 Lunch break (Posters and YouTube viewing) Session 2A Vaccination 2A: optimizing programs in a situation of limited resources 13:00-13:30 Keynote Vaccination: overcoming the constraints to achieving effective immunity rates A. Dekker 13:30-13:45 Intra-dermal vaccination with 1/10 dose against FMDV protects pigs as well against clinical disease and subclinical virus shedding as intra-muscular vaccination with a full dose P. Eblé 13:45-14:00 Vaccination strategies in sheep and lambs by using commercial polyvalent oil adjuvanted vaccines E. Smitsaart 14:00-14:15 Longevity of protection following vaccination with high potency FMD vaccines in cattle – preliminary results S. Cox 14:15-14:30 Discussion of session 2A 14:30-14:45 High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus B. Haas 14:45-15:00 Predicting antigenic sites on the FMDV capsid from cross-reactivity data F. Maree 15:00-15:15 Vaccine matching: reliability of foot-and-mouth disease r-values determination N. Mattion Coffee break (Posters and YouTube viewing) 15:15-15:45 15:45-16:00 Session 2 B Vaccination - 2B: overcoming antigenic diversity in simplifying preventive programs. OIE/FAO FMD lab network Towards vaccine selection guidelines for each regional virus pool 16:00-16:15 Discussion of session 2B Session 2C Novel vaccine delivery approaches: progress updates 16:15-16:30 16:30-16:45 16:45-17:00 Expression of foot-and-mouth disease virus capsid proteins in Silkworm-Baculovirus expression system and its utilization as an empty capsid vaccine Zhifang Zhan Potential of modified vaccinia Ankara (MVA) virus as a vaccine delivery vector for foot-and-mouth disease virus (FMDV) J. Castillo-Olivares Marker potential of a vaccine prepared from a foot-and-mouth disease virus with a partial VP1 G-H loop deletion P. V. Barnett 17:00-18:30 Poster session 18:30-20:30 Dinner 20:30-21:15 Frenkel Lecture: B. Charleston FMD vaccine development - past and future Wednesday 15 October 08:15-08:45 08:45-09:00 Session 2D FMD vaccine standards required for global control 09:00-09:15 Can serological methods reliably replace existing vaccine challenge tests? R. Reeve Keynote Vaccine quality tests: the value of alternative methods? N. Goris A standardized direct contact challenge method for FMDV in swine L. Rodriguez 09:15-09:30 Correlating vaccine induced protection with humoral and cellular immune responses to FMDV: Potential in vitro assays for replacement of potency test S. Parida 09:30-09:45 Altenative Potency Test in FMD vaccines G. Aynagoz 09:45-10:00 Discussion of session 2D 10:00-10:30 Coffee break (Posters and YouTube viewing) Session 3 Biosecurity and buy-in 10:30-11:00 11:00-11:15 11:15-11:30 11:30-11:45 Keynote Biosecurity: what’s in it for me? N. Honhold FMD control in endemic settings: critical controls approach using livestock market chain and risk analysis J. Pinto Bridging the divide between two bona fide guardians of society’s interests: the disease exterminators and the sustainable growth advocates B. Perry Discussion of session 3 Session 4 Measure progress in global and regional FMD control, and early warning of FMDV emergence 11:45-12:15 12:15-12:45 Keynote New options for old problems: endemic strains and early warning of emergence D. Paton 12:45-13:30 13:30-13:45 13:45-14:00 Lunch break (Posters and YouTube viewing) Global surveillance of foot-and-mouth disease: concepts, considerations and requirements A. M. Perez Sampling, shipping, organisation and testing of inactivated samples to take advantage of molecular analysis methods S. Alexandersen Discussion of session 4 14:00-14:15 Use of infrared thermography to detect signs of foot-and-mouth disease in wild ungulates M. R. Dunbar 14:15-14:30 Sequence identification and genetic profile of FMDV in disease outbreaks using rapid full length genomic analysis S. Metwally 14:30-14:45 Identification of virulence determinants in FMDV: potential use of functional genomics to predicting viral pathotypes L. Rodriguez 14:45-15:00 The distribution of NSP positive animals in regular vaccinated herds as criterion for effectiveness of vaccine and vaccination during endemic year H. Yadin 15:00-15:15 Measuring the success of vaccination programs: lessons learnt from surveys in Brazil 2005-2006 H. Barbosa 15:15-20:00Excursion and dinner 21:15-22:00 Fred Brown debate, Gavin Thomson: Management of FMD caused by SAT-type viruses in southern Africa: present approaches to control and trade standards are inappropriate Thursday 16 October Session 5 Diagnostics: making quality services available where need Parallel Session 5 Epidemiology 08:15-08:45 Keynote Diagnostics: a new era in access to high performance diagnostics? D. King 08:45-09:00 FMD and SVD combined proficiency test studies 2008 – Virological Assays N. Ferris 08:15-08:30 Anticipatory control measures: geographical information systems-based identification of topographic factors acting as obstacles or disseminators in the 2001 Uruguayan FMD epidemics A. Rivas 08:30-08:45 Network analysis of livestock movements to estimate potential silent spread of foot-and-mouth disease in Canada C. Dubé 08:45-09:00 Modelling of FMD outbreaks in the Netherlands, and the impact of vaccination on freedom of infection H. Roermund 09:00-09:15 09:15-09:30 Defining the period of infectiousness of cattle naturally infected with foot-and-mouth disease virus P. V. Barnett 09:00-09:30 09:30-09:52 FMD and SVD combined proficiency test studies 2008 serology Y. Li 09:52-10:15 To be announced Keynote Driving up global standards for FMD diagnostic: a key role for proficiency testing and international organisations K. De Clercq 10:15-10:45 Coffee break (Posters and YouTube viewing) 10:45-11:00 An advanced field deployable “Pen Side” sample preparation and PCR system C. Volpe Sequence data to support a possible case of airborne spread of foot-and-mouth disease virus that occurred during the UK 2001 epidemic G. König 11:00-11:15 Validation of real-time RT-PCR: matrix effect, uncertainty of measurement and precision K. De Clercq 09:30-09:45 Localisation of foot-and-mouth disease virus after acute infection N. Juleff 11:15-11:30 Development of prototype solid phase competitive ELISAs based on monoclonal antibodies for the serology of FMDV serotypes SAT1 and SAT2 E. Brocchi 09:45-10:00 Investigations into findings of FMD seropositive sheep and goats in Cyprus, an FMD-free country D. Paton 11:30-11:45 Full genome sequencing to support tracing of UK outbreaks of FMD N. Knowles 10:00-10:15 Results of molecular testing of samples from Pakistan S. Alexandersen 10:15-10:45 Coffee break (Posters and YouTube viewing) 10:45-11:00 Tracing 2007–2008 foot-and-mouth disease emergency episodes in South America: molecular epidemiology I.E. Bergman 11:00-11:15 Sero-prevalence of foot-and-mouth disease in small ruminants under contrasting husbandry practices in Western Uganda S. Balinda 11:15-11:30 The study on Sero-prevalence of foot-and-mouth disease (FMD) in Ethiopia G. Ayelet Session 6 Components and capacity for effective control 14:00-14:15 Factors influencing global FMD reporting and risk R. Garabed Parallel Session 6 Diagnostics 11:45-12:00 DIVA test evaluation in Jordanian sheep and cattle S. Parida 12:00-12:30 Panel discussion and debate Diagnostic kits -what are the gaps? RL and NRL viewpoints from across the globe R. Dwarka, N. Thanh Long, R. Venkataraman 12:30-14:00 Lunch break and poster session 14:15-14:30 14:30-14:45 Participatory epidemiology as compared to conventional FMD surveillance tool T. Rufael 14:45-15:00 Development of an improved capability in support of national bio-security for the surveillance and control of foot-and-mouth disease in cattle and pigs in Viet Nam C. Morrissy 15:00-15:15 OIE Statement discussion To be announced 13:45:14:00 To be announced 14:00-14:15 Detection of FMDV serotypes O, A and Asia 1 by real-time RT-PCR S. Reid 14:15-14:30 Linear-After-The-Exponential (LATE) PCR: New detection technologies for pan-FMDV and serotype-specific assays in the fiel K. E. Pierce 14:30-14:45 Evaluation of a lateral flow device for the pen-side diagnosis of foot-and-mouth N. Ferris 14:45-15:00 Detection of persistently FMDV infected cattle by Salivary IgA Test J. Biswal 15:00-15:15 Development and evaluation of IgM test for detection of FMDV U. Waheed Session 7 Prospects for integrating anti-viral approaches 15:15-15:30 Enhanced prospects for FMDV anti-virals targeted to the 3C protease S. Curry 15:30-15:45 In Vivo Activity of T-1105 against the highly pathogenic, pig-adapted strain, FMDV O/Taw/1997 K. Sakamoto 15:45-16:15 Coffee break (Posters and YouTube viewing) Session 8 Strategy for regional and global control 16:15-16:30 Elements of a global strategy FAO 16:30-17:00 Panel discussion and debate Session 9 Final Session 17:00-17:30 Recommendations of the Session EuFMD 17:30 Closing cerimony Friday 17 17:30-20:00 Dinner October 8:30-13:00 14:00-17:00 Closed session of the Standing Technical Committee GFRA meeting Food and Agriculture Organization of the United Nations poster session Diagnostics A. Yakovleva Development of indirect ELISA for detection of antibodies to foot-and-mouth disease virus non-structural proteins Foetal goat tongue cell line is highly sensitive for foot-and-mouth disease virus B. Haas B.S. Chang Validation of solid phase epitope blocking ELISA (SPEBE) to detect antibodies against type O foot-and-mouth disease virus using recombinant pentamer like structure proteins C. Morrissy Development of a foot-and-mouth disease (FMD) 3ABC nonstructural antibody C-ELISA using chicken anti-3ABC as the completing antibody E. Brocchi Evaluation of profiling ELISA for antibodies to non structural proteins of foot-and-mouth disease virus for DIVA-serology E. Brocchi K. Morioka Preliminary evaluation of panels of monoclonal antibodies developed against four vaccine strains of FMD viruses of serotype A for antigenic profiling and vaccine matching of field isolates L. Bakkali-Kassimi Baculovirus expression of non-structural protein 3D of FMDV and its use as antigen in ELISA for differentiation of infected from vaccinated animals Diagnostic strategy for FMDV - the Bulgarian approach L. Polihronova FMDV antigen detection ELISA using multi-serotype reactive monoclonal antibodies R. Mistry Detection of foot-and-mouth disease virus on an automated sample preparation and PCR point-of-care instrument S. Grazioli Mapping of linear antigenic sites of the non structural protein 3D of foot-and-mouth disease relevant for the recognition of an infection status Epidemiology C. Wright Human nasal FMDV carriage after exposure to infected animals J. Gloster Airborne spread of foot-and-mouth disease – model intercomparison M. Habiela Epizootiological study of FMD in Sudan (The situation after two decades) M. Shalev Foot-and-mouth disease in North American wildlife and potential strategies for its detection monitoring, and management N. Knowles Genetic variation of foot-and-mouth disease viruses isolated from free-living African buffalo (Syncerus Caffer) in Zimbabwe N. Knowles Virus nomenclature and framework of reference strains for phylogenetic analysis D. Abdollahi NSP and Sp induced by FMD vaccines used in I. R. Iran S. M. Jamal Status of foot-and-mouth disease in Pakistan Global Control D. Geale Novel Funding Sources for Hemispheric Improvement of foot-and-mouth disease (FMD) preparedness and response: Project scope & Progress to date Inter-American group for the eradication of foot-and-mouth disease (GIEFA) D. Geale A. Seitzinger Estimating the economic impact of potential FMD outbreaks based on the North American animal disease spread model (NAADSM) simulation results Other J. H. Park Effective inhibition of foot-and-mouth disease virus by multiple short hairpin RNAS expression in A adenovirus R. Waters An in-vitro cell culture model, investigating infection of novel cell types with foot-and-mouth disease Z. Zhang Development of a cell line stably expressing T7 RNA polymerase using retroviral gene transfer technology for efficient rescue of infectious foot-and-mouth disease virus from cloned cDNA M. Rémond Immunity, Vaccines and Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigen Z. Zhang Impact of cytokine response on FMDV infection outcome in cattle Measurement of FMDV antigen stability using single domain antibody fragments Vaccination M. Harmsen A. Dekker A. Summerfield The relation antibody and protection after foot-and-mouth disease vaccination cannot be standardized A. Timina Study of immnunobiologic characteristics of type Asia-1 No. 1987/Amursky/2005 FMD virus A. Dekker Intratype heterologous vaccination in cattle can confer antibody response in presence of maternally derived antibodies Population dynamics of a SAT type FMD chimeric vaccine strain B. Blignaut Innate immune defences induced by CpG formulation in a conventional foot-and-mouth disease vaccine do not promote protection D. Gibson Understanding FMDV transmission between vaccinated cattle – preliminary data from animal experiment E. Blanco Dendrimeric peptides as potential subunit vaccines against FMD E. Lefevre A quantitative assessment of primary and secondary immune responses in cattle using the B cell ELISPOT assay Piglets with maternally derived antibodies can be vaccinated at 2 weeks of age G. Chenard M. Mahapatra Use of recombinant alpha v beta 6 integrin to improve the antigenic profiling ELISA for FMD vaccine strain selection M. Trotta In vivo and in vitro test to detect non-structural proteins in foot-and-mouth disease vaccines. M. Windsor Dissecting the early immune response to FMD in cattle. P. Eblé Quantification of transmission of FMDV strain Asia-1 Turkey among vaccinated and non-vaccinated lambs Cliptox increased the protection levels induced by an FMDV inactivated vaccine P. Zamorano R.B.Borrego Targeting FMDV minigenes to SLA II positive cells enhances the induction of cellular responses in swine and confers protection against viral challenge CD4+ T cell Responses to foot-and-mouth disease virus (FMDV) in vaccinated Cattle. V. Carr V. Quattrocchi Development of a fast release immunomodulated vaccine against foot-and-mouth disease virus. Induced immunity